Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Provention Bio Initiates Rolling Submission of BLA for Teplizumab for Type 1 Diabetes

americanpharmaceuticalreviewApril 17, 2020

Tag: Provention Bio , Teplizumab , type 1 diabetes

PharmaSources Customer Service